dipyridamole has been researched along with Skin Diseases in 8 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eight patients with livedo vasculitis of four to 30 years' duration that was unresponsive to a variety of medications were treated with pentoxifylline." | 7.67 | Livedo vasculitis. Therapy with pentoxifylline. ( Sams, WM, 1988) |
| "Eight patients with livedo vasculitis of four to 30 years' duration that was unresponsive to a variety of medications were treated with pentoxifylline." | 3.67 | Livedo vasculitis. Therapy with pentoxifylline. ( Sams, WM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Child, N | 1 |
| Anjum, N | 1 |
| Keohane, SG | 1 |
| Cooper, HL | 1 |
| Agirbasli, M | 1 |
| Eren, M | 1 |
| Eren, F | 1 |
| Murphy, SB | 1 |
| Serdar, ZA | 1 |
| Seckin, D | 1 |
| Zara, T | 1 |
| Cem Mat, M | 1 |
| Demirkesen, C | 1 |
| Vaughan, DE | 1 |
| Thiers, B | 1 |
| Drucker, CR | 1 |
| Duncan, WC | 1 |
| Stahl, D | 2 |
| Thomsen, K | 2 |
| Hou-Jensen, K | 2 |
| Levine, SR | 1 |
| Langer, SL | 1 |
| Albers, JW | 1 |
| Welch, KM | 1 |
| Sams, WM | 1 |
1 review available for dipyridamole and Skin Diseases
| Article | Year |
|---|---|
A guide to anticoagulation and endocarditis prophylaxis during cutaneous surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Anticoagulants; Aspirin; Calcium Ch | 2010 |
7 other studies available for dipyridamole and Skin Diseases
| Article | Year |
|---|---|
Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy.
Topics: Adolescent; Adult; Aspirin; Dipyridamole; Female; Fibrinolysis; Humans; Male; Plasminogen Activator | 2011 |
Therapeutic briefs. I.
Topics: Adult; Anti-Bacterial Agents; Aspirin; Child; Cimetidine; Cyclophosphamide; Dipyridamole; Female; Hu | 1980 |
Antiplatelet therapy in atrophie blanche and livedo vasculitis.
Topics: Adult; Aged; Aspirin; Atrophy; Blood Platelets; Dipyridamole; Female; Humans; Male; Middle Aged; Pla | 1982 |
Degos' disease treated with platelet-suppressive drugs.
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Male; Skin; Skin Diseases; Syndrome | 1977 |
Malignant atrophic papulosis: treatment with aspirin and dipyridamole.
Topics: Adult; Aspirin; Dipyridamole; Humans; Infarction; Male; Platelet Aggregation; Skin; Skin Diseases; T | 1978 |
Sneddon's syndrome: an antiphospholipid antibody syndrome?
Topics: Antibodies; Aspirin; Blood Coagulation Factors; Cardiolipins; Cerebral Infarction; Dipyridamole; Fem | 1988 |
Livedo vasculitis. Therapy with pentoxifylline.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ma | 1988 |